Innovators in Cancer Immunology: Ovarian Cancer
珀金埃尔默使用cookies来确保我们为您提供在我们网站上的最佳体验。 这可能包括来自第三方网站的cookies。 如果您不改变您的设置点击继续,我们会认为您同意接收本网站的cookies。 您可以随时更改您的Cookie设置。 要了解更多信息,请查看我们的Cookie政策,其中包含有关如何管理Cookie的信息。

Innovators in Cancer Immunology: Ovarian Cancer

June 20, 2017

Innovators in Cancer Research: Ovarian Cancer


Michael Feldman, MD, PhD
Associate Professor of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania Philadelphia, PA

To advance the understanding of disease mechanisms in cancer, it is critical that researchers see everything a tumor has to show them. Leveraging PerkinElmer’s Phenoptics Quantitative Pathology Research Solutions, researchers are now visualizing and measuring tumor cells and multiple immune-cell phenotypes simultaneously for the first time in formalin-fixed paraffin-embedded (FFPE) tissue.

Because of Phenoptics’ integration of multiplexed immunohistochemistry and imaging, leading scientists are now able to quantitatively capture systems biology data in cellular detail. What follows are brief profiles of some of these Innovators in Cancer Immunology and how they are using Phenoptics to discover new insights into the complexity of immune-cancer interactions that affect countless millions of patients around the world.

Dr. Michael Feldman is a longtime thought leader in the drive to modernize pathology. He has been actively integrating image analysis, algorithms, digital imaging technology, and informatics to address the shortcoming of conventional immunohistochemistry (IHC) and visual perception. Dr. Feldman is an early adopter of PerkinElmer’s Phenoptics technology, and today is focusing on merging quantitative pathology approaches with digital pathology platforms, workflows, and laboratory information systems., Dr. Feldman most recently used Phenoptics imaging capabilities to automate the challenging visual task of assessing TIL counts on conventional, 3-color,chromogenic immunohistochemistry (IHC) instrument.

更多故事关于 生命科学, 病理研究

Innovators in Cancer Immunology: Lymphoma

Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a lymphoma cancer case study, Dr. Rodig uses t...

Innovators in Cancer Immunology: Breast Cancer

Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a breast cancer case study, Dr. Rimm uses this...